- Home
- CRNX vs SKWD Comparison
CRNX vs SKWD Comparison
Compare CRNX & SKWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- SKWD
- Stock Information
- Founded
- CRNX 2008
- SKWD 2007
- Country
- CRNX United States
- SKWD United States
- Employees
- CRNX N/A
- SKWD N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- SKWD Property-Casualty Insurers
- Sector
- CRNX Health Care
- SKWD Finance
- Exchange
- CRNX Nasdaq
- SKWD Nasdaq
- Market Cap
- CRNX 2.8B
- SKWD 2.3B
- IPO Year
- CRNX 2018
- SKWD 2023
- Fundamental
- Price
- CRNX $29.20
- SKWD $48.06
- Analyst Decision
- CRNX Strong Buy
- SKWD Buy
- Analyst Count
- CRNX 8
- SKWD 11
- Target Price
- CRNX $74.86
- SKWD $63.00
- AVG Volume (30 Days)
- CRNX 806.6K
- SKWD 441.1K
- Earning Date
- CRNX 08-07-2025
- SKWD 07-30-2025
- Dividend Yield
- CRNX N/A
- SKWD N/A
- EPS Growth
- CRNX N/A
- SKWD 6.84
- EPS
- CRNX N/A
- SKWD 3.16
- Revenue
- CRNX $760,000.00
- SKWD $1,253,720,000.00
- Revenue This Year
- CRNX $409.34
- SKWD $18.15
- Revenue Next Year
- CRNX $773.02
- SKWD $11.63
- P/E Ratio
- CRNX N/A
- SKWD $15.65
- Revenue Growth
- CRNX N/A
- SKWD 21.67
- 52 Week Low
- CRNX $24.10
- SKWD $34.10
- 52 Week High
- CRNX $62.53
- SKWD $65.05
- Technical
- Relative Strength Index (RSI)
- CRNX 37.84
- SKWD 31.08
- Support Level
- CRNX $27.60
- SKWD $48.58
- Resistance Level
- CRNX $31.50
- SKWD $50.13
- Average True Range (ATR)
- CRNX 1.21
- SKWD 1.49
- MACD
- CRNX -0.33
- SKWD -0.17
- Stochastic Oscillator
- CRNX 9.89
- SKWD 6.97
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About SKWD Skyward Specialty Insurance Group Inc.
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.